Atrophic vaginitis is typically associated with the hypoestrogenic state of menopause. However, lactation also decreases estrogen levels and can cause symptomatic urogenital atrophy. Discussion of ...

Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H2 2016" report to their offering. Pharmaceutical and ...

Amneal announced the availability of Yuvafem (estradiol vaginal inserts), a generic version of Vagifem. Yuvafem is an estrogen product indicated for use in atrophic vaginitis due to menopause. It ...

If a woman is being treated with topical estrogen for atrophic vaginitis, does she need to use a progestin (synthetic progesterone) to protect the uterus? The best clinical practice at this point in ...

The FDA has approved a 10mcg formulation of Vagifem (estradiol vaginal tablets, from Novo Nordisk) for the treatment of atrophic vaginitis due to menopause. This approval is based on clinical data ...

Bachmann G, Lobo RA, Gut R, Nachtigall L, Notelovitz M. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol 2008;111:67 ...

The vagina is the outer portion of the birthing canal that encloses the mouth of the uterus or the cervix. It is lined with mucous membranes and normally the female hormone estrogen helps to keep ...

Please provide your email address to receive an email when new articles are posted on . At 12 weeks, vaginal hyaluronic acid and vaginal estrogen were associated with genitourinary syndrome of ...

Vaginitis is an inflammation of the vagina that can result in discharge, itching, and pain. The cause is usually a change in the normal balance of vaginal bacteria or an infection. Reduced estrogen ...